Yiguanjian and Chaihujialonggumuli Decoction for Treatment of Depression after Stroke 30 Cases Clinical Observation
Zhang Xiaojian
Abstract
Zhang Xiaojian
Abstract
[Objective]Yiguanjian and Chaihujialonggumuli Decoction for treatment of post-stroke depression liver-kidney patients.[Method]30 patients were divided into treatment group and control group of 30 patients,two groups were given conventional vascular therapy,the treatment group Yiguanjian and Chaihujialonggumuli Decoction,the control group took Flupentixol film melitracen.[Results]The total effective rate was 90% in the control group,the total efficiency of 70%.[Conclusion] Yiguanjian and Chaihujialonggumuli Decoction reliable efficacy in the treatment of depression after stroke.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective]Yiguanjian and Chaihujialonggumuli Decoction for treatment of post-stroke depression liver-kidney patients.[Method]30 patients were divided into treatment group and control group of 30 patients,two groups were given conventional vascular therapy,the treatment group Yiguanjian and Chaihujialonggumuli Decoction,the control group took Flupentixol film melitracen.[Results]The total effective rate was 90% in the control group,the total efficiency of 70%.[Conclusion] Yiguanjian and Chaihujialonggumuli Decoction reliable efficacy in the treatment of depression after stroke.
Key concepts: Medicine, Decoction, Post-stroke depression, Depression (economics), Stroke (engine), Treatment and control groups, Internal medicine, Clinical efficacy